Abstract
BackgroundImmune suppression is common in neoplasia and a major driver is tumor-induced myeloid dysfunction. Yet, overcoming such myeloid cell defects remains an untapped strategy to reverse suppression and improve host...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have